Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00285_DB01026_nanopub.RAvbhbR8X2OVcXIZfk0AibMycnEPJ8OgKWj8u2y6lbBG0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00285_DB01026 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00285_DB01026 label "DDI between Venlafaxine and Ketoconazole - Ketoconazole, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Venlafaxine, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Venlafaxine if Ketoconazole is initiated, discontinued, or dose changed. [drugbank_resource:DB00285_DB01026]" assertion.
- drugbank_resource:DB00285_DB01026 identifier "drugbank_resource:DB00285_DB01026" assertion.
- drugbank_resource:DB00285_DB01026 title "DDI between Venlafaxine and Ketoconazole - Ketoconazole, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Venlafaxine, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Venlafaxine if Ketoconazole is initiated, discontinued, or dose changed." assertion.
- drugbank:DB00285 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00285_DB01026 assertion.
- drugbank:DB01026 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00285_DB01026 assertion.